Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-10,000
-
Total reported value, excl. options
-
$0
-
Value change
-
-$1,521
-
Number of sells
-
-1
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q2 2025
1 filing reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q2 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.